Asia · Financial press · The Economic Times

Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares

Published by The Economic Times · India 1 h ago

Moderna shares plunged after detailed cancer vaccine trial results triggered profit-taking despite reducing melanoma recurrence risk by 42%. Investors weigh commercial prospects,…

Read the full article on The Economic Times Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (economictimes.indiatimes.com)

Also worth reading

SCMP Business

Market sell-off, tax scrutiny and growth: key figures shaping investor sentiment

Caixin Global

In Depth: China’s Offshore Trust Tax Grace Period Ends as Questions Linger

Nikkei Asia

Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares

Share

Also worth reading

Market sell-off, tax scrutiny and growth: key figures shaping investor sentiment

In Depth: China’s Offshore Trust Tax Grace Period Ends as Questions Linger

Chinese stocks fight economic gloom after slide into bear territory